Introduction
Many U.S. companies operate through multiple entities, including LLCs, holding companies, or subsidiaries, to manage liability, optimize funding, or streamline operations. Individual taxpayers may own one or more companies with partners, family, or friends. This can create related entities for tax purposes under federal and state tax codes, which have special rules when claiming the R&D tax credit for their businesses or as passthrough owners. For R&D tax credits, the IRS treats related entities as a single taxpayer under IRC Section 41(f) when they qualify as a controlled group. This allows qualified research expenses (QREs) to be aggregated and the resulting credit to be allocated across entities in a fair and compliant way.
Understanding these aggregation rules can make a major difference. IRS examiner guidance notes that many multi-entity businesses miss legitimate credits because they file separately when a single combined calculation should apply. Failure to follow these rules can result in disallowed credits and potential penalties. Companies should file Form 6765 with proper treatment of expenses across entities within the group, including disclosure of all entities in the controlled group and each member’s qualified research expenses.
What Is a Controlled Group for R&D Tax Credits?
Direct answer: A controlled group exists when two or more entities, including corporations, LLCs, or partnerships, share more than 50 percent common ownership as defined under IRC Section 41(f)(5) and Treas. Reg. § 1.41-6. A controlled group can also exist when five or fewer persons own at least 80 percent of two or more entities and have more than 50 percent identical ownership. That is the brother-sister test imported from IRC Section 1563. Group membership is determined as of December 31 of the taxable year under IRC Section 1563(b). Aggregation can apply to corporations, partnerships, and LLCs through the rules of Sections 1563 and 52.
Understanding the examples
In the table below, generic names such as Entity A or Subsidiary A and B are used only for illustration. They represent typical ownership structures that determine whether multiple businesses must aggregate R&D activities for credit purposes.
These ownership tests apply consistently when computing the federal R&D credit, with non-corporate entities included under common control rules.
How Controlled Groups Claim the R&D Credit
Follow these four steps to properly aggregate and allocate R&D credits across a controlled group.
1) Aggregate QREs
Combine qualified research expenses across entities that perform qualified activities, including wages, supplies, and contract research. Exclude funded research under IRC Section 41(d)(4)(H). Inside the group, intragroup payments are generally disregarded: the performing entity claims its in-house QREs and the payor does not claim contract research for intragroup work under Treas. Reg. Section 1.41-6(i)(2). For third-party contracts, the claimant depends on who bears financial risk and retains substantial rights.
2) Compute the group credit
- Regular Method: 20 percent of QREs above the fixed base under IRC Section 41(a)(1).
- ASC Method: 14 percent of QREs above 50 percent of the average from the prior three years under IRC Section 41(c)(5).
All members must use the same method. The ASC election must be made on a timely filed original return and continues until revoked prospectively. It cannot be made on an amended return, and there is no late-election relief under Treas. Reg. Section 301.9100-3.
3) Allocate pro rata
Distribute the total credit based on each entity’s contribution:
Entity allocation = (Entity QRE ÷ Total QRE) × Total Credit.
4) File using Form 6765
Each entity files its share, indicates controlled group status, and attaches computations showing each member’s QREs, credit percentage, and allocation. See the January 2025 Instructions for Form 6765. For tax years beginning in 2025, Section G’s business-component reporting is optional per IRS announcement IR-2025-99. If completing Section G, list components in descending order until at least 80 percent of QREs are covered, up to 50 components per entity, and aggregate the remainder. Section G becomes mandatory for tax year 2026, with certain exceptions for small businesses .IRS Form 6765 Instructions (January 2025)
How Aggregation Multiplied a Group’s R&D Credits
A fictional example for demonstration purposes
A tech group with three entities had only the testing entity claiming about 120,000 dollars per year in R&D credits. All three entities had identical ownership among four shareholders, creating a brother-sister controlled group under IRC Section 41(f)(5).
After proper aggregation and allocation:
- Total QREs: $5.8M dollars combined.
- Calculated group credit: $532,000 using the ASC method
Computation: 14% of the excess over 50% of a $4M average.
Excess equals $5.8M minus $2.0M equals $3.8M. - Allocation: Manufacturing $2.5M QREs → $229,310. Testing $2.3M→ $210,966. Software $1.0M → $91,724.
- Outcome: Total credits rose from $120,000 to $532,000 due to proper aggregation and documentation.
Numbers rounded for clarity.
Common Mistakes in Controlled-Group R&D Credit Filings
Best Practices for Controlled-Group Planning
- Update ownership mapping annually, especially after M&A or reorganizations.
- Track QREs by performing entity to avoid duplication.
- Centralize the group’s R&D credit computation and maintain consistent methods.
- Use accounting integrations to tie wages and supply costs to R&D activities.
- Review state rules. More than 35 states offer R&D credits, and many follow federal aggregation principles. Specific rules vary by state, including California.
Quick Wins
- Conduct a controlled-group ownership review within 60 days after any M&A event.
- Amend open tax years, generally up to three prior years, for eligible adjustments under IRC Section 6511.
- Maintain a unified R&D ledger for all entities to simplify future filings.
Why Controlled-Group Planning Matters
Aggregating R&D activities across related entities often increases available credits for multi-entity groups. With Form 6765’s 2025 emphasis on business-component detail, strong documentation and consistent credit methods are essential for optimization and audit readiness.
FAQs: Controlled-Group R&D Tax Credits
What defines a controlled group for R&D tax credits
Entities with more than 50 percent common ownership under IRC Section 41(f)(5), including parent-subsidiary, brother-sister, and combined structures. Group membership is determined on December 31 under Section 1563(b).
Can each entity file its own Form 6765?
Yes. Each entity files its allocated share with the group’s combined computation attached.
What if one company performs no R&D?
It remains part of the group but receives no allocation if it has no QREs.
Do these rules apply to LLCs and partnerships?
Yes. Treas. Reg. Section 1.41-6 and Section 52 common control rules bring non-corporate entities into aggregation when applicable.
How far back can missed credits be claimed?
Generally up to three years through amended returns under IRC Section 6511.
Do state R&D credits follow the same rules?
More than 35 states offer credits. Many align with federal aggregation concepts, but details vary by state.
How is the credit rate determined?
Regular Method is 20 percent over the base. ASC Method is 14 percent over 50 percent of the prior three-year average.
What if ownership changes mid-year?
Allocation is based on year-end membership, with timing coordination under Treas. Reg. Section 1.41-6(g). It is not a day-count proration rule.
How do groups elect a credit method?
Make the ASC election on a timely filed original return. It cannot be made on an amended return, and there is no late-election relief under Treas. Reg. Section 301.9100-3.
What changed in Form 6765 for 2025?
Section G business-component reporting is optional for tax years beginning in 2025 per IR-2025-99. It becomes mandatory for tax year 2026, with certain small business exceptions.
Final Thoughts
Controlled-group aggregation turns complex ownership structures into significant R&D opportunities. By following IRS guidance, aggregating QREs correctly, and allocating credits transparently, multi-entity organizations can secure substantial federal and state tax savings while staying fully compliant.
Want to confirm your eligibility?
Request a 2025 R&D credit review with our team at Strike Tax Advisory.
Official Sources:
- IRS – Form 6765 (Credit for Increasing Research Activities)
- IRS – Instructions for Form 6765 (2025)
- Treas. Reg. § 1.41-6 – Controlled Group Rules
Disclaimer: This article is for general informational purposes only and does not constitute tax advice.
